GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tryptamine Therapeutics Ltd (OTCPK:TYPTF) » Definitions » FCF Margin %

TYPTF (Tryptamine Therapeutics) FCF Margin % : 0.00% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Tryptamine Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tryptamine Therapeutics's Free Cash Flow for the six months ended in Dec. 2024 was $-3.26 Mil. Tryptamine Therapeutics's Revenue for the six months ended in Dec. 2024 was $0.00 Mil. Therefore, Tryptamine Therapeutics's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Tryptamine Therapeutics's current FCF Yield % is -12.11%.

The historical rank and industry rank for Tryptamine Therapeutics's FCF Margin % or its related term are showing as below:

TYPTF' s FCF Margin % Range Over the Past 10 Years
Min: -9653   Med: -5160.19   Max: -667.37
Current: -786.27

During the past 6 years, the highest FCF Margin % of Tryptamine Therapeutics was -667.37%. The lowest was -9653.00%. And the median was -5160.19%.

TYPTF's FCF Margin % is ranked worse than
76.48% of 1012 companies
in the Biotechnology industry
Industry Median: -129.705 vs TYPTF: -786.27

Tryptamine Therapeutics FCF Margin % Historical Data

The historical data trend for Tryptamine Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tryptamine Therapeutics FCF Margin % Chart

Tryptamine Therapeutics Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
FCF Margin %
Get a 7-Day Free Trial - - - -9,691.43 -667.95

Tryptamine Therapeutics Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Dec24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -244.90 -1,272.51 - -

Competitive Comparison of Tryptamine Therapeutics's FCF Margin %

For the Biotechnology subindustry, Tryptamine Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tryptamine Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tryptamine Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tryptamine Therapeutics's FCF Margin % falls into.


;
;

Tryptamine Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tryptamine Therapeutics's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-2.772/0.415
=-667.95 %

Tryptamine Therapeutics's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-3.263/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tryptamine Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Tryptamine Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tryptamine Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tryptamine Therapeutics Ltd (OTCPK:TYPTF) » Definitions » FCF Margin %
Comparable Companies
ASX:SPL ASX:CYP ASX:PTX ASX:ILA ASX:ADO ASX:ATX ASX:NOX ASX:ATH ASX:NYR ASX:BTC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
TYP:Australia
Address
C/o Bio101 Financial Advisory Pty Ltd, 697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124
Website
https://www.tryptherapeutics.com
Tryptamine Therapeutics Ltd is a clinical-stage biotechnology company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. Its product pipeline includes TRP-8803 (IV-infused psilocin) and TRP-8802 (oral psilocybin).

Tryptamine Therapeutics Headlines

From GuruFocus

Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement

By PRNewswire PRNewswire • 01-31-2022

Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines

By PRNewswire PRNewswire • 12-22-2021